Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Kinex Pharmaceuticals, LLC

Kinex Pharmaceuticals is developing next generation anti-cancer drugs that target the molecular basis of disease. The Company uses a proprietary technology platform to generate compounds that inhibit the Protein Kinase and Phosphatase family of proteins.Protein kinases and phosphatases are families of proteins that are intimately involved in transmitting signals across the cell membrane. They control critical events such as cell proliferation, cell movement and cell death. Abnormally elevated activity of both protein kinases and phosphatases is associated with a number of diseases, including cancer. Inhibitors of these target proteins have proven to be useful drugs in fighting cancer.


Contact Details:
701 Ellicott Street
Buffalo
New York
14203
United States of America
Tel:716.881.8984
Fax:716.849.6651
Email:jlau@kinexpharma.com
WWW:

www.kinexpharma.com/




Loading...

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 346 times since April 2007, the link to the organisation's website has been followed 63 times

Search for more companies in Buffalo

Search for more companies in New York



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Kinex Pharmaceuticals, LLC

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.